全文获取类型
收费全文 | 1640篇 |
免费 | 205篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 63篇 |
妇产科学 | 45篇 |
基础医学 | 209篇 |
口腔科学 | 47篇 |
临床医学 | 311篇 |
内科学 | 259篇 |
皮肤病学 | 84篇 |
神经病学 | 149篇 |
特种医学 | 92篇 |
外科学 | 151篇 |
综合类 | 22篇 |
预防医学 | 185篇 |
眼科学 | 22篇 |
药学 | 66篇 |
肿瘤学 | 136篇 |
出版年
2024年 | 4篇 |
2023年 | 30篇 |
2022年 | 20篇 |
2021年 | 42篇 |
2020年 | 28篇 |
2019年 | 19篇 |
2018年 | 70篇 |
2017年 | 49篇 |
2016年 | 67篇 |
2015年 | 73篇 |
2014年 | 89篇 |
2013年 | 97篇 |
2012年 | 125篇 |
2011年 | 133篇 |
2010年 | 82篇 |
2009年 | 78篇 |
2008年 | 95篇 |
2007年 | 98篇 |
2006年 | 88篇 |
2005年 | 101篇 |
2004年 | 63篇 |
2003年 | 58篇 |
2002年 | 61篇 |
2001年 | 19篇 |
2000年 | 21篇 |
1999年 | 27篇 |
1998年 | 26篇 |
1997年 | 24篇 |
1996年 | 25篇 |
1995年 | 8篇 |
1994年 | 13篇 |
1993年 | 11篇 |
1992年 | 16篇 |
1991年 | 8篇 |
1990年 | 11篇 |
1989年 | 9篇 |
1987年 | 6篇 |
1985年 | 3篇 |
1984年 | 9篇 |
1983年 | 6篇 |
1982年 | 2篇 |
1979年 | 2篇 |
1977年 | 4篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1974年 | 3篇 |
1973年 | 2篇 |
1972年 | 3篇 |
1969年 | 3篇 |
1968年 | 5篇 |
排序方式: 共有1855条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
Daryl J. Higgins President Psychologist BA Grad Dip Pastoral Couns. PhD MAPS 《Sexual and Relationship Therapy》2013,28(2):217-220
Abstract The purpose of this paper is to review the phenomenon of same-sex attraction in married men. As well as looking at a variety of reasons that gay and bisexual men provide for getting married, the author describes a model that incorporates a variety of possible theoretical explanations. Finally, practical implications for therapists are provided, focusing on identity development and support. 相似文献
35.
36.
Mertens J Stock S Lüngen M V Berg A Kr?mer U Filipiak-Pittroff B Heinrich J Koletzko S Grübl A Wichmann HE Bauer CP Reinhardt D Berdel D Gerber A 《Pediatric allergy and immunology》2012,23(6):597-604
To cite this article: Mertens J, Stock S, Lüngen M, Berg AV, Kr?mer U, Filipiak-Pittroff B, Heinrich J, Koletzko S, Grübl A, Wichmann H-E, Bauer C-P, Reinhardt D, Berdel D, Gerber A. Is Prevention of Atopic Eczema with Hydrolyzed Formulas Cost-Effective? A Health Economic Evaluation from Germany. Pediatr Allergy Immunol 2012: 23: 597-604. ABSTRACT: Objective: The German Infant Nutritional Intervention (GINI) trial, a prospective, randomized, double-blind intervention, enrolled children with a hereditary risk for atopy. When fed with certain hydrolyzed formulas for the first 4?months of life, the risk was reduced by 26-45% in PP and 8-29% in intention-to-treat (ITT) analyses compared with children fed with regular cow's milk at age 6. The objective was to assess the cost-effectiveness of feeding hydrolyzed formulas. Patients and Methods: Cost-effectiveness was assessed with a decision tree model programmed in TreeAge. Costs and effects over a 6-yr period were analyzed from the perspective of the German statutory health insurance (SHI) and a societal perspective at a 3% effective discount rate followed by sensitivity analyses. Results: The extensively hydrolyzed casein formula would be the most cost-saving strategy with savings of 478?€ per child treated in the ITT analysis (CI95%: 12?€; 852?€) and 979?€ in the PP analysis (95%CI: 355?€; 1455?€) from a societal perspective. If prevented cases are considered, the partially whey hydrolyzed formula is cost-saving (ITT -5404?€, PP -6358?€). From an SHI perspective, the partially whey hydrolyzed formula is cost-effective, but may also be cost-saving depending on the scenario. An extensively hydrolyzed whey formula also included into the analysis was dominated in all analyses. Conclusions: For the prevention of AE, two formulas can be cost-effective or even cost-saving. We recommend that SHI should reimburse formula feeding or at least the difference between costs for cow's milk formula and the most cost-effective formula. 相似文献
37.
38.
Histopathological evaluation of duodenal biopsy in the PreventCD project. An observational interobserver agreement study
下载免费PDF全文
![点击此处可从《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Vincenzo Villanacci Luisa Lorenzi Francesco Donato Renata Auricchio Piotr Dziechciarz Judit Gyimesi Sibylle Koletzko Zrinjka Mišak Vanesa Morente Laguna Isabel Polanco David Ramos Raanan Shamir Riccardo Troncone Sabine L. Vriezinga M. Luisa Mearin 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2018,126(3):208-214
Aim of the current study was to evaluate the inter‐observer agreement between pathologists in the diagnosis of celiac disease (CD), in the qualified context of a multicenter study. Biopsies from the “PreventCD” study, a multinational‐ prospective‐ randomized study in children with at least one‐first‐degree relative with CD and positive for HLA‐DQ2/HLA‐DQ8. Ninety‐eight biopsies were evaluated. Considering diagnostic samples with villous atrophy (VA), the agreement was satisfactory (κ = 0.84), but much less when assessing the severity of these lesions. The use of the recently proposed Corazza‐Villanacci classification showed a moderately higher level of agreement (κ = 0.39) than using the Marsh‐Oberhuber system (κ = 0.31). 57.1% of cases were considered correctly oriented. A number of >4 samples per patient was statistically associated to a better agreement; orientation did not impact on κ values. Agreement results in this study appear more satisfactory than in previous papers and this is justified by the involvement of centers with experience in CD diagnosis and by the well‐controlled setting. Despite this, the reproducibility was far from optimal with a poor agreement in grading the severity of VA. Our results stress the need of a minimum of four samples to be assessed by the pathologist. 相似文献
39.
40.
Sibylle de Germay Manuela Rueter Franois Montastruc Vanessa Rousseau Maryse Lapeyre‐Mestre Jean‐Louis Montastruc 《Fundamental & clinical pharmacology》2019,33(4):471-478
Atropinic drugs are known to potentially induce physical and/or mental impairments in the elderly. The aim of this study was to investigate trends of atropinic exposure in patients ≥65 years in France between 2006 and 2015. A repeated cross‐sectional study was performed quarterly from January 1, 2006 to December 31, 2015, in the ‘Echantillon Généraliste des Bénéficiaires (EGB)’, a representative sample of the French population. Exposed patients were identified using the Anticholinergic Durán's list. Outcomes were rate of patients exposed to at least one atropinic drug (atropinic prevalence rate) and atropinic burden per patient (sum of atropinic burden scores). Interrupted time series were used to analyze the impact of market withdrawal of some drugs with atropinic properties during the period of the study. The number of patients ≥65 years registered in the EGB ranged from 75 611 in 2006 to 95 389 in 2015. Atropinic prevalence rate decreased significantly from 45.6% in 2006 to 33.2% in 2015 (?12.4%, slope significance P < 0.05). Subjects aged ≥85 years were the most exposed. Total atropinic burden decreased significantly between 2006 and 2015 (2.2 ± 1.7 in 2006; 2.0 ± 1.5 in 2015; slope significance P < 0.05), especially in patients ≥85 years. Market withdrawals for safety reasons of some atropinic drugs were significantly associated with a decrease in the atropinic prevalence rate (P < 0.05) and atropinic burden per patient (P < 0.05). In conclusion, atropinic drug exposure in the elderly significantly decreased in France between 2006 and 2015. This decrease can be partly explained by regulatory measures against some atropinic drugs. 相似文献